"I was expecting him probably to win. It was very big win," Pfizer's CEO Albert Bourla said of President Donald Trump's ...
By Christy Santhosh (Reuters) -Pfizer CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to its ...
As biopharma players continue to parse out what the second Trump administration means for the industry, Pfizer CEO Albert ...
CEO Albert Bourla said on Monday that the drugmaker could move some of its overseas manufacturing to its U.S. plants if ...
Pfizer CEO Albert Bourla on Monday said that the company might move overseas manufacturing to its existing plants in the ...
Pfizer CEO Albert Bourla announced the possibility of shifting overseas manufacturing to U.S. plants. This response is due to ...
Says “I don’t think the Street” has adjusted yet and that “they should have a look on it.” The company says the rebates that Pfizer (PFE) will ...
The US president has imposed a 10 per cent tariff across all Chinese imports into the US and proposed a 25 per cent levy on ...
Pfizer made changes to its DEI webpage, joining other companies across different industries repositioning their messaging ...
A study by KFF found that one in four Republican parents now say they've skipped or delayed some childhood vaccines as of ...
Pfizer is pulling further away from the gene therapy field with its decision to discontinue hemophilia product Beqvez. | ...
Albert Bourla, the CEO of Pfizer, stated that the company is prepared to move its overseas manufacturing to the U.S. if ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results